Literature DB >> 21560254

Neurocognitive impairment in childhood-onset systemic lupus erythematosus: measurement issues in diagnosis.

Tricia S Williams1, Cynthia Aranow, Gail S Ross, Alexandra Barsdorf, Lisa F Imundo, Andrew H Eichenfield, Philip J Kahn, Betty Diamond, Deborah M Levy.   

Abstract

OBJECTIVE: To assess the prevalence of neurocognitive impairment (NCI) in childhood-onset systemic lupus erythematosus (cSLE) by comparing published classification criteria, and to examine associations between NCI, disease characteristics, psychosocial well-being, and intelligence.
METHODS: cSLE patients and ethnicity- and age-matched healthy controls completed a neuropsychological research battery, and results were categorized by 3 different NCI classification criteria with different cutoff scores (e.g., >2, 1.5, or 1 SD below the mean) and the number of required abnormal tests or domains.
RESULTS: Forty-one cSLE subjects and 22 controls were included. Subjects were predominantly female (~70%) and Hispanic (∼70%). Executive functioning, psychomotor speed, and fine motor speed were most commonly affected. Method 1 classified 34.1% of cSLE subjects with NCI compared to method 2 (14.6% with decline and 7.3% with NCI) and method 3 (63.4% with NCI). The prevalence of NCI was not significantly different between the controls and patients using any of the categorization methods. NCI was not associated with SLE disease activity or characteristics or with depression. Using method 3, patients in the cognitive impairment group reported significantly lower quality of life estimates (69.7 versus 79.3; P = 0.03). Below average intellectual functioning (intelligence quotient <90) differentiated the number of test scores >1 and >1.5 SDs, but not >2 SDs below the mean.
CONCLUSION: NCI was prevalent in cSLE, but varied according to the chosen categorization method. A similar proportion of cSLE patients and controls had NCI, reinforcing the importance of studying an appropriate control group. Categorical classification (i.e., impaired/nonimpaired) may oversimplify the commonly observed deficits in cSLE.
Copyright © 2011 by the American College of Rheumatology.

Entities:  

Mesh:

Year:  2011        PMID: 21560254      PMCID: PMC3149725          DOI: 10.1002/acr.20489

Source DB:  PubMed          Journal:  Arthritis Care Res (Hoboken)        ISSN: 2151-464X            Impact factor:   4.794


  41 in total

1.  Maturation of cognitive processes from late childhood to adulthood.

Authors:  Beatriz Luna; Krista E Garver; Trinity A Urban; Nicole A Lazar; John A Sweeney
Journal:  Child Dev       Date:  2004 Sep-Oct

2.  Antiphospholipid antibodies and the antiphospholipid syndrome. Clinical relevance in neuropsychiatric systemic lupus erythematosus.

Authors:  D Alarcón-Segovia; B Estañol; G García-Ramos; A R Villa
Journal:  Ann N Y Acad Sci       Date:  1997-08-14       Impact factor: 5.691

Review 3.  White matter: organization and functional relevance.

Authors:  Christopher M Filley
Journal:  Neuropsychol Rev       Date:  2010-03-31       Impact factor: 7.444

4.  Neurological manifestations of children with systemic lupus erythematosus.

Authors:  W F Loh; I M Hussain; A Soffiah; Y N Lim
Journal:  Med J Malaysia       Date:  2000-12

Review 5.  Neurocognitive impairment in children and adolescents with systemic lupus erythematosus.

Authors:  Deborah M Levy; Stacy P Ardoin; Laura E Schanberg
Journal:  Nat Clin Pract Rheumatol       Date:  2009-02

6.  The incidence and prevalence of neuropsychiatric syndromes in pediatric onset systemic lupus erythematosus.

Authors:  Wilmer L Sibbitt; John R Brandt; Courtney R Johnson; Marcos E Maldonado; Samir R Patel; Corey C Ford; Arthur D Bankhurst; William M Brooks
Journal:  J Rheumatol       Date:  2002-07       Impact factor: 4.666

7.  Neurologic manifestations of pediatric systemic lupus erythematosus.

Authors:  M I Steinlin; S I Blaser; D L Gilday; A A Eddy; W J Logan; R M Laxer; E D Silverman
Journal:  Pediatr Neurol       Date:  1995-10       Impact factor: 3.372

8.  Relationship between health-related quality of life and SLE activity and damage in children over time.

Authors:  L N Moorthy; M G E Peterson; A L Hassett; M Baratelli; E C Chalom; P J Hashkes; S Hong; A Reiff; T J A Lehman
Journal:  Lupus       Date:  2009-06       Impact factor: 2.911

Review 9.  The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus.

Authors:  D Gladman; E Ginzler; C Goldsmith; P Fortin; M Liang; M Urowitz; P Bacon; S Bombardieri; J Hanly; E Hay; D Isenberg; J Jones; K Kalunian; P Maddison; O Nived; M Petri; M Richter; J Sanchez-Guerrero; M Snaith; G Sturfelt; D Symmons; A Zoma
Journal:  Arthritis Rheum       Date:  1996-03

10.  Patterns of cognitive impairment in patients with systemic lupus erythematosus.

Authors:  J D Fisk; B Eastwood; G Sherwood; J G Hanly
Journal:  Br J Rheumatol       Date:  1993-06
View more
  16 in total

1.  Diagnosis of cognitive impairment in adult and pediatric SLE.

Authors:  John G Hanly; John D Fisk
Journal:  Nat Rev Rheumatol       Date:  2011-08-23       Impact factor: 20.543

2.  Cognitive Function in Children with Lupus Nephritis: A Cross-Sectional Comparison with Children with Other Glomerular Chronic Kidney Diseases.

Authors:  Andrea Knight; Amy J Kogon; Matthew B Matheson; Bradley A Warady; Susan L Furth; Stephen R Hooper
Journal:  J Pediatr       Date:  2017-07-19       Impact factor: 4.406

3.  Validation of the Pediatric Automated Neuropsychological Assessment Metrics in childhood-onset systemic lupus erythematosus.

Authors:  Hermine I Brunner; Marisa S Klein-Gitelman; Frank Zelko; Erin C Thomas; Jessica Hummel; Shannen M Nelson; Jennifer Huggins; Megan L Curran; Tresa Roebuck-Spencer; Dean W Beebe; Jun Ying
Journal:  Arthritis Care Res (Hoboken)       Date:  2013-03       Impact factor: 4.794

4.  Academic outcomes in childhood-onset systemic lupus erythematosus.

Authors:  Frank Zelko; Dean Beebe; Aimee Baker; Shannen M Nelson; Aisha Ali; Adlin Cedeno; Blair Dina; Marisa S Klein-Gitelman; Jun Ying; Hermine I Brunner
Journal:  Arthritis Care Res (Hoboken)       Date:  2012-08       Impact factor: 4.794

5.  Cognitive Performance Scores for the Pediatric Automated Neuropsychological Assessment Metrics in Childhood-Onset Systemic Lupus Erythematosus.

Authors:  Patricia Vega-Fernandez; Shana Vanderburgh White; Frank Zelko; Natasha M Ruth; Deborah M Levy; Eyal Muscal; Marisa S Klein-Gitelman; Adam M Huber; Lori B Tucker; Tresa Roebuck-Spencer; Jun Ying; Hermine I Brunner
Journal:  Arthritis Care Res (Hoboken)       Date:  2015-08       Impact factor: 4.794

6.  Childhood-onset lupus with clinical neurocognitive dysfunction shows lower streamline density and pairwise connectivity on diffusion tensor imaging.

Authors:  J T Jones; M DiFrancesco; A I Zaal; M S Klein-Gitelman; D Gitelman; J Ying; H I Brunner
Journal:  Lupus       Date:  2015-02-19       Impact factor: 2.911

Review 7.  Challenges of Diagnosing Cognitive Dysfunction With Neuropsychiatric Systemic Lupus Erythematosus in Childhood.

Authors:  Ashwaq AlE'ed; Patricia Vega-Fernandez; Eyal Muscal; Claas H Hinze; Lori B Tucker; Simone Appenzeller; Brigitte Bader-Meunier; Johannes Roth; Vicenç Torrente-Segarra; Marisa S Klein-Gitelman; Deborah M Levy; Tresa Roebuck-Spencer; Hermine I Brunner
Journal:  Arthritis Care Res (Hoboken)       Date:  2017-08-29       Impact factor: 4.794

Review 8.  Cognitive and emotional abnormalities in systemic lupus erythematosus: evidence for amygdala dysfunction.

Authors:  Philip Watson; Justin Storbeck; Paul Mattis; Meggan Mackay
Journal:  Neuropsychol Rev       Date:  2012-08-11       Impact factor: 7.444

Review 9.  Systemic lupus erythematosus in children and adolescents.

Authors:  Deborah M Levy; Sylvia Kamphuis
Journal:  Pediatr Clin North Am       Date:  2012-04       Impact factor: 3.278

10.  Functional neuronal network activity differs with cognitive dysfunction in childhood-onset systemic lupus erythematosus.

Authors:  Mark W DiFrancesco; Darren R Gitelman; Marisa S Klein-Gitelman; Anna Carmela P Sagcal-Gironella; Frank Zelko; Dean Beebe; Todd Parrish; Jessica Hummel; Jun Ying; Hermine I Brunner
Journal:  Arthritis Res Ther       Date:  2013-03-07       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.